News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Dan Goldstaub: Lots of progress at ESMO meeting 2024
Photo taken from Dan Goldstaub/LinkedIn
Sep 19, 2024, 11:34

Dan Goldstaub: Lots of progress at ESMO meeting 2024

Dan Goldstaub, Co-Founder of PhaseV, shared on LinkedIn:

“An overwhelming ESMO meeting 2024 ended in Barcelona!

Lots of progress, new treatments, biomarkers and analysis tools.
Not enough tools coordinating all those into a more successful clinical trial, and that is where we, PhaseV, step in!”

Source: Dan Goldstaub/LinkedIn

More posts featuring ESMO24 on oncodaily.com

cancer Dan Goldstaub ESMO ESMO24 OncoDaily Oncology PhaseV
Special Coverage
Insight
Nov 14, 2024, 16:22
Guru P. Sonpavde: Largest analysis of association of irAEs efficacy
Blog
Nov 14, 2024, 16:22
Yara Abdou: Our ASCO editorial on assessing target expression for ADC efficacy
Insight
Nov 14, 2024, 16:13
Aaron Goodman: Hematology Fellow Board Review
Blog
Nov 14, 2024, 16:03
Nicholas Dadarino: The immune landscape of recurrent GBM
Insight
Nov 14, 2024, 15:58
Iván R. González: Warning on Sotorasib Treatment for Advanced Lung Cancer
Insight
Nov 14, 2024, 15:54
Applications for the NKI PhD program are open
Opinion
Nov 14, 2024, 15:53
The role of reirradiation in recurrent glioblastoma 
Insight
Nov 14, 2024, 15:50
Nina Sanford: SAbR vs. SBRT
Blog
Nov 14, 2024, 15:49
Stephen Liu: Proud to co-host the official IASLC podcast with Narjust Florez
Insight
Nov 14, 2024, 15:47
Anirban Maitra: Clinical functional proteomics of intercellular signalling in Pancreatic Cancer
Insight
Nov 14, 2024, 15:41
Pasquale Pisapia: The relevance of the reference range for EGFR testing in non-small cell lung cancer patients
Blog
Nov 14, 2024, 15:40
Ajay Major: Next-Generation Sequencing (NGS) variants prior to CAR